Trial Profile
Extracellular and Intracellular TFV/FTC Residues After a Single Dose in HIV-Negative Men and Women: Implications for Pre-exposure HIV Prophylaxis Dosing of Truvada.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2012
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms TAIL
- 05 Apr 2011 New trial record